Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform

/PRNewswire/ -- Jnana Therapeutics ("Jnana"), a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for...

Related Keywords

Boston ,Massachusetts ,United States ,Ron Renaud ,Joelc Barrish ,Joanne Kotz ,Bain Capital Life Sciences ,Linkedin ,Twitter ,Drug Administration ,Pediatric Disease ,Polaris Partners ,Versant Ventures ,Avalon Ventures ,Rare Pediatric Disease Designation ,Managing Director ,Pfizer Ventures ,Jnana Therapeutics ,